FDA Class II · Drug · April 29, 2026
Furosemide Tablets recall — Leading Pharma, LLC
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Official ID D-0486-2026 · Official record ↗
Leading Pharma recalls
Recall found. Leading Pharma is named in FDA Class II recall D-0486-2026 covering Furosemide Tablets. Hazard: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. Identifying details: Lots# H03125, H03225, H03325, Exp Date: 2027/08. Status: Ongoing.
Models with recalls
All Leading Pharma recalls
Verify with the official sources:
- CPSC — consumer products ↗ (aggregated here)
- NHTSA — vehicles, car seats, tires ↗ (aggregated here; use NHTSA's VIN lookup to check a specific vehicle)
- FDA — food, drugs, medical devices ↗ (aggregated here)
- USDA FSIS — meat, poultry & processed egg products ↗ (not aggregated here)
- Recalls.gov — the U.S. government’s all-agency portal ↗
Found something wrong or missing? Report a data error.
Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.